Cover Image

Burden of Invasive Fungal Diseases in Patients With Alcohol‐Related Hepatitis and Organ Failure

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Charlotte Mouliade, Lucia Parlati, Stylianos Tzedakis, Mathis Collier, Samir Bouam, Philippe Sogni, Fanny Lanternier, Alexandre Alanio, Vincent Mallet
Format:	Artículo Open Access
Published:	Wiley 2025
Subjects:	Alimentary Pharmacology & Therapeutics
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Editorial: When Yeast Turns Beast—Unmasking an Overlooked Threat in Alcohol‐Related Hepatitis. Authors' Reply
by: Vincent Mallet, et al.
Published: (2025)

Safety and Tolerability of Injectable Extended‐Release Naltrexone for the Management of Alcohol Use Disorder in Advanced Alcohol‐Associated Liver Disease
by: Luis Antonio Díaz, et al.
Published: (2025)

Disordered Bile Acid Metabolism in Alcohol‐Related Hepatitis
by: Luke D. Tyson, et al.
Published: (2026)

Letter: Predictors of Corticosteroid Response in Alcohol‐Related Hepatitis
by: Ewan Forrest, et al.
Published: (2025)

Editorial: Decoding Gut Failure in Cirrhosis—Villin‐1 and the Emergence of a Seventh Organ Failure. Authors' Reply
by: David Tornai, et al.
Published: (2026)

Alcohol‐Attributable Cancer: Update From the Global Burden of Disease 2021 Study
by: Pojsakorn Danpanichkul, et al.
Published: (2025)

Letter: Predictors of Corticosteroid Response in Alcohol‐Related Hepatitis—Authors' Reply
by: Francisco Idalsoaga, et al.
Published: (2025)

Meta‐Analysis: Mortality Trends and Risk Factors in Severe Alcohol‐Associated Hepatitis
by: Mushfiqur R. Siddique, et al.
Published: (2025)

Editorial: When Yeast Turns Beast—Unmasking an Overlooked Threat in Alcohol‐Related Hepatitis
by: Maaz Arif, et al.
Published: (2025)

Letter: Refining Mortality Estimates in Severe Alcohol‐Associated Hepatitis—Addressing Heterogeneity and Prognostic Assessment
by: Shupeng Zhao, et al.
Published: (2025)

Letter on ‘Meta‐Analysis: Mortality Trends and Risk Factors in Severe Alcohol‐Associated Hepatitis’—Authors' Reply
by: Francisco Idalsoaga, et al.
Published: (2025)

Comparison Between Dynamic Models for Predicting Response to Corticosteroids in Alcohol‐Associated Hepatitis: A Global Cohort Study
by: Francisco Idalsoaga, et al.
Published: (2025)

Letter: Refining Mortality Estimates in Severe Alcohol–Associated Hepatitis—Addressing Heterogeneity and Prognostic Assessment. Authors' Reply
by: Francisco Idalsoaga, et al.
Published: (2025)

Advanced Fibrosis and Cardiometabolic Risk Burden Increase Major Cardiovascular Events in Chronic Hepatitis C Patients With Steatotic Liver Disease After Viral Eradication
by: Pei‐Chien Tsai, et al.
Published: (2025)

Effect of Nucleos(t)ide Analogues Withdrawal on Survival Outcomes in Patients With Hepatitis B Virus‐Related Acute‐on‐Chronic Liver Failure
by: Yanxue Lin, et al.
Published: (2025)

Impact of Evolving Evidence on Pharmacological Therapy for Alcohol‐Associated Hepatitis in Alberta: A Population‐Based Study of Practice Trends and MELD ‐Stratified Effectiveness of Corticosteroids
by: Abdel‐Aziz Shaheen, et al.
Published: (2026)

Letter: Trajectories of Hepatic Function Markers Enable Early Prediction of Hepatic Recompensation
by: Benedikt Silvester Hofer, et al.
Published: (2026)

Editorial: The Hidden Burden—Stigmatisation in Inflammatory Bowel Disease
by: Marco Vincenzo Lenti, et al.
Published: (2025)

Unveiling Drug‐Induced Autoimmune‐Like Hepatitis in Autoimmune Hepatitis Patients: A Multicenter Retrospective Study
by: Pinelopi Arvaniti, et al.
Published: (2025)

Letter on ‘Unveiling Drug‐Induced Autoimmune‐Like Hepatitis in Autoimmune Hepatitis Patients: A Multicenter Retrospective Study’
by: Muhammad Ibrahim Khalil, et al.
Published: (2025)

Editorial: The Relevance of Hepatic Flares and Quantitative Hepatitis B Surface Antigen After Stopping HBV Polymerase Inhibitors
by: Stefan Mauss
Published: (2025)

Letter: Global Burden of Metabolic Dysfunction‐Associated Steatotic Liver Disease‐Related Liver Cancer—Results From the Global Burden of Disease Study 2021
by: Chunlong Liu, et al.
Published: (2025)

Global Burden of Gallbladder Cancer Attributable to Modifiable Risk Factors
by: Daniele Piovani, et al.
Published: (2025)

Impact of GLP‐1 Receptor Agonists on Alcohol‐Related Liver Disease Development and Progression in Alcohol Use Disorder
by: Chia‐Chih Kuo, et al.
Published: (2025)

Hepatic Events During Immune Checkpoint Inhibitor Treatment Between Liver and Non‐Liver Malignancies in Hepatitis B Endemic Areas
by: Yi‐Ping Hung, et al.
Published: (2024)

Editorial: The Relevance of Hepatic Flares and Quantitative Hepatitis B Surface Antigen After Stopping HBV Polymerase Inhibitors—Authors' Reply
by: Ying‐Nan Tsai, et al.
Published: (2025)

Successful Amendment of an Existing Hepatitis B Screening Programme by a Guideline Recommended Hepatitis D Screening in the Primary Care Setting
by: Toni Herta, et al.
Published: (2024)

Hepatitis B Immunoglobulins Withdrawal in Hepatitis B Virus Mono‐Infected Liver Transplant Recipients: An Italian Multicentre Prospective Study
by: Raffaella Viganò, et al.
Published: (2025)

Editorial: The Hidden Burden—Stigmatisation in Inflammatory Bowel Disease: Authors' Reply
by: Suprabhat Giri, et al.
Published: (2025)

Editorial: Right‐Sizing Colonoscopy Referrals for Patients With Possible Signs and Symptoms of Colorectal Cancer
by: Nicole P. Mirabadi, et al.
Published: (2025)

Letter: Safety and Tolerability of Injectable Extended Release Naltrexone for the Management of Alcohol Use Disorder in Advanced Alcohol‐Associated Liver Disease
by: Xing Bai, et al.
Published: (2025)

M et ALD : Diagnosis and Prognosis With Non‐Invasive Tests
by: Nikolaj Torp, et al.
Published: (2025)

Letter: Safety and Tolerability of Injectable Extended‐Release Naltrexone for the Management of Alcohol Use Disorder in Advanced Alcohol‐Associated Liver Disease—Authors' Reply
by: Luis Antonio Díaz, et al.
Published: (2025)

Tenofovir Alafenamide Therapy Throughout Pregnancy in Mothers With Hepatitis B
by: Xingfei Pan, et al.
Published: (2025)

Surviving Hepatitis C—Understanding Death and Survival Beyond Cure
by: Paul J. Clark, et al.
Published: (2025)

Autoimmune Hepatitis and Vitamin D Deficiency: A Nationwide Perspective
by: Yassine Kilani, et al.
Published: (2024)

Editorial: Metabolic Dysfunction and Alcohol—Two Sides of the Same Coin
by: Gustavo Ayares, et al.
Published: (2024)

Affinity Proteomics‐Based Non‐Invasive Detection of Clinically Significant Liver Disease
by: Sriram Balasubramani, et al.
Published: (2026)

Editorial: Hepatitis C virus eradication improves skeletal muscle mass
by: Catherine Jia Lin Tian, et al.
Published: (2024)

Editorial: Addressing Unmet Needs and Socioeconomic Disparity in Patients With Autoimmune Hepatitis
by: Seren Gedallovich, et al.
Published: (2024)